ESC Premium Access

A specific complex I-induced ROS modulator, OP2113, is a new cardioproctective agent against acute myocardial infarction injuries during reperfusion.

Congress Presentation

About the speaker

Doctor Aurelie Boucard

OP2 Drugs, Bordeaux (France)
0 follower

12 more presentations in this session

Strict versus no fasting prior to cardiac catheterization: a prospective evaluation of safety and clinical outcomes

Speaker: Doctor A. Mishra (Sayre, US)

Thumbnail

Intraventricular conduction disturbance and ventricular paced rhythms in patients with acute coronary syndromes

Speaker: Doctor P. Azevedo (Faro, PT)

Thumbnail

Reduced exercise capacity and clinical outcomes following acute myocardial infarction

Speaker: Doctor H. Tashiro (Nagoya, JP)

Thumbnail

Ultrasound targeted delivery of exosomes derived from bone mesenchymal stem cells stimulate angiogenesis and reduce adverse remodeling after myocardial infarction

Speaker: Doctor Q. Deng (Wuhan, CN)

Thumbnail

Exercise training after acute coronary syndromes in the octogenarians has beneficial effect on the course of the disease and the exercise tolerance - single-center, prospective 12-months evaluation.

Speaker: Professor R. Dabrowski (Warsaw, PL)

Thumbnail

Access the full session

Poster Session 5 - Acute coronary syndrome treatment

Speakers: Doctor A. Boucard, Doctor A. Mishra, Doctor P. Azevedo, Doctor H. Tashiro, Doctor Q. Deng...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk